Results 121 to 130 of about 565,290 (205)

Rethinking asthma therapy, part 2: transdermal strategies for adjunct asthma and allergy treatments. [PDF]

J Pharm Pharm Sci
Correa J, Brogden NK.
europepmc   +1 more source

Production of cromolyn sodium microparticles for aerosol delivery by supercritical assisted atomization. [PDF]

AAPS PharmSciTech, 2007
Reverchon E, Adami R, Caputo G.
europepmc   +1 more source

Análise dos efeitos de medicamentos antiasmáticos, da bradicinina e da substância P no modelo experimental da Pleurisia em Camundongos [PDF]

, 1996
Saleh, Tânia Silvia Frode
core  

Alveolar macrophages initiate the spatially targeted recruitment of neutrophils after nanoparticle inhalation. [PDF]

Sci Adv
Liu Q, Yang L, Li C, Han L, Wilmot J, Yang G, Leinardi R, Zhou Q, Schröppel A, Kutschke D, Secklehner J, Yldirim AÖ, Huaux F, Zeuschner D, Carlin LM, Sperandio M, Schmid O, Stoeger T, Rehberg M.   +18 more
europepmc   +1 more source

Mast Cell Activation Affecting Gastrointestinal Motility. [PDF]

J Neurogastroenterol Motil
Singh B, Grover P, Kaur G.
europepmc   +1 more source

Insulin Pump-Induced Lipoatrophy: Proposed Diagnostic and Management Algorithm. [PDF]

JCEM Case Rep
Kanagaretnam H, Parameshwaran K, Suryawanshi A.   +2 more
europepmc   +1 more source

Systemic Mastocytosis: Molecular Pathophysiology, WHO Diagnostic Framework, and <i>KIT</i>-Directed Targeted Therapies. [PDF]

Cancers (Basel)
Alati C, Greve MB, Porto G, Policastro G, Bilardi E, Utano G, Giordano L, Pitea M, Martino M.   +8 more
europepmc   +1 more source

Mast cell-5-HT-HTR2A axis involvement in chronic itch induced by SADBE. [PDF]

Mol Pain
Fan L, Nong X, Ni M, Chen X, Zeng L, Chen H, Wang J, Ouyang X, Tao A, Liu X.   +9 more
europepmc   +1 more source

Eosinophilic gastroenteritis in a 45-year-old female with epigastric abdominal pain: a rare case report. [PDF]

Ann Med Surg (Lond)
Mousa A, Daas L, Hababeh MN, Alhofari B, Thalaj L, Al Erksoussi L, Abo Shukr J, Salman L, Sleiay B, Sleiay M.   +9 more
europepmc   +1 more source

Denosumab as a Potential Disease-Modifying Treatment in Indolent Systemic Mastocytosis-Related Osteoporosis. [PDF]

JCEM Case Rep
Abbas M, Luthra P.
europepmc   +1 more source